In between 6% and 12% of pregnancies' the fetal membranes rupture spontaneously before labour begins-a condition still (rather unsatisfactorily) called "premature" rupture of the membranes. If the pregnancy is at term labour usually follows or is induced with oxytocin to avoid possible infection. In about 2-3% of pregnancies, however, the membranes rupture before 37 weeks' gestation.2 This condition is best called "preterm" rupture of the membranes1 3: it occurs in around one-third of all preterm deliveries,2 and its management raises difficult questions.
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Usually no cause can be found, but a few cases are due to trauma, hydramnios, or cervical incompetence.4 Normally the tensile strength of the membranes is higher in midpregnancy than at term5 6: some investigators5 have reported an abnormally low collagen content in membranes that rupture spontaneously before term, but others6 have found no such abnormality and suggest that the rupture is due to localised weakness. Infection might be a cause,7 since amnionitis is more frequent4 when the membranes rupture just before labour than when they rupture just after its onset,4 and because preterm rupture of the membranes is more common8 when there is vaginal colonisation with group B streptococci.
Diagnosis9 is usually based on the history, the results of examination with a sterile speculum (not digitally), and possibly testing the pool of liquid in the vagina with nitrazine. Urinary incontinence may be distinguished by giving the woman oral phenazopyridine to stain the urine. In the few cases'0 in which the diagnosis is still not clear staining of the amniotic fluid by amniocentesis has been suggested,9 10 but the risks include adverse effects of dye on the fetus," and most obstetricians would prefer to avoid this investigation.
Management presents the two problems of avoiding infection and minimising the risks of prematurity. A recent study in Oxford showed bacterial colonisation in 41% of neonates after preterm rupture of the membranes, compared with 28% after premature rupture of the membranes at term and 23% of term infants after elective amniotomy.2 Bacterial colonisation correlated poorly, however, with chorioamnionitis.
Seven of the 42 preterm infants in this survey died, but only one death was associated with septicaemia, the rest being due to complications of prematurity. The authors concluded that the major risk to the neonate in these cases is not infection but preterm delivery. The same conclusion has been reached elsewhere,2 12-15 and the evidence justifies the current trend towards conservative treatment.'6 Furthermore, the risk of amnionitis does not increase with the passage of time after rupture of the membranes13 (at least among preterm pregnancies17). In one American study9 of 188 patients with premature rupture of the membranes treated conservatively there were no neonatal deaths from sepsis even though 19% of the patients went beyond seven days before labour began. In another study'8 of 116 patients with preterm rupture the incidence of amnionitis before labour was 500 and of neonatal sepsis 700; three babies died from prematurity and one fetal death was associated with infection. How 18 have suggested that respiratory distress syndrome becomes less likely the longer delivery is delayed after the membranes rupture, but other studies'3 25 26 have found that rupture of the membranes itself does not accelerate maturation of the lung. There seems no basis9 for fears that giving steroids to stimulate production of surfactant might increase the risk of infection, and a study27 of immunoglobulins in the cord blood has suggested that treatment with steroids does not interfere with the fetal humoral response. Steroids have to be given at least 24 hours before delivery to have any useful effects, and treatment with ritodrine to diminish uterine contractions may delay labour for 24 hours14 despite the presence of ruptured membranes-though there is no evidence that ritodrine is effective for more than 24 hours in these circumstances or that such "tocolytic" treatment alone reduces the incidence of respiratory distress. The effectiveness of treatment with steroids may sometimes be monitored by estimating the lecithin:sphingomyelin ratio28 or the phosphatidylglycerol content29 of the fluid draining from the vagina (provided contamination with maternal urine is avoided28); otherwise some obstetricians recommend amniocentesis,3 17 30 though theoretically this might increase the risk of infection. ' respectively. Up till now most investigators have studied broad groups of dermatophyte infections, and it would be most helpful to substantiate these observations in specific forms of dermatophytosis such as tinea capitis.
The value of ketoconazole in chronic mucocutaneous candidiasis has been established in several studies, including one placebo-controlled trial.5 A substantial proportion of treated patients with chronic mucocutaneous candidiasis achieve complete mycological and clinical-remission. In one study six out of 17 patients relapsed with oral infection within 8-4 months of stopping the drug but responded to retreatment.6 These results in an infection such as chronic mucocutaneous candidiasis are encouraging and hold out hope that similar persistent infections will respond as well. Ketoconazole is active against vaginal candidiasis and is likely to prove more acceptable to patients than topical treatment. As even short regimens of topical drugs have proved to be highly effective, however, the comparative merits of ketoconazole need to be carefully assessed.
Few reports have appeared of the use of ketoconazole in the subcutaneous mycoses, though some therapeutic effect has been described in chromomycosis.1 Some of the systemic mycoses, however, particularly certain forms of paracoccidioidomycosis,7 respond dramatically to the drug. Some clinical varieties of coccidioidomycosis and histoplasmosis may also respond.'
As yet the value of k'rtoconazole cannot be assessed in opportunistic fungal infections such as systemic candidiasis or
